References
- Isojarvi J, Laatikainen TJ, Pakarinen AJ, van Parys J, Rattya J, Harbo HF, Dale PO, Fauser BC, Gjerstad L, Koivunen R, Knip M, Tapanainen JS: Polycystic ovaries and hyperandro-genism in women taking valproate for epilepsy. N Engl J Med 1993; 329:1383–1388
- Murialdo G, Galimberti CA, Magri F, Sampaolo P. Copello F, Gianelli MV, Gazzerro E, Rollero A, Deagatone C, Manni R, Ferrari E, Polled A, Tartara A: Menstrual cycle and ovary alterations in women with epilepsy on antiepileptic therapy. J Endocrinol Invest 1997; 20:519–526
- Murialdo G, Galimberti CA, Gianelli MV, Rollero A, Polleni A, Copello F, Magri F, Ferrari E, Sampaolo P, Manni R, Tartara A: Effects of valproate, phenobarbital, and carbamazepine on sex steroid setup in women with epilepsy. Clin Neuropharma-col 1998; 21:52–58
- Bauer .1, lame A, Klingmuller D, Elger CE: Polycystic ovary syndrome in patients with focal epilepsy: A study in 93 women. Epilepsy Res 2000; 41:163–167
- Eberle AJ: Valproate and polycystic ovaries. J Am Acad Child Adolesc Psychiatry 1998; 37:1009
- Singh KB, Mahajan DK, Wortsman J: Effect of obesity on the clinical and hormonal characteristics of the polycystic ovary syndrome. J Reprod Med 1994; 39:805–808
- McKenna Ti: Pathogenesis and treatment of polycystic ovar-ian syndrome. N Engl J Med 1988; 318:558–562
- Badawy SZA: The relation between obesity and testosterone-estradiol binding globulin levels in PCOS. Diagn Gynecol Obstet 1980; 2:43–46
- Rasgon NL, Altshuler LL, Gudeman D, Burt VK, Tanavoli S, Hendrick V, Korenman S: Medication status and polycystic ovary syndrome in women with bipolar disorder: A prelimi-nary report. J Clin Psychiatry 2000; 61:173–178
- Allison DB, Casey DE: Antipsychotic-induced weight gain: A review of the literature. J Clin Psychiatry 2001; 62(Suppl 7):22–31
- Allison DB, Mentore JL, Heo M, Chandler LP, Cappelleri JC, Infante MC, Weiden PJ: Antipsychotic-induced weight gain: A comprehensive research synthesis. Am I Psychiatry 1999; 156:1686–1696
- Meltzer HY, Goode DJ, Schyve PM, Young M, Fang VS: Effect of clozapine on human serum prolactin levels. Am J Psychiatry 1979; 136:1550–1555
- Kane JM, Cooper TB, Sachar EJ, Halpern FS, Bailine S: Clozapine: Plasma levels and prolactin response. Psychophar-macology (Berl) 1981; 73:184–187
- Baptista T, Reyes D, Hernandez L: Antipsychotic drugs and reproductive hormones: Relationship to body weight regulation. Pharmacol Biochem Behav 1999; 62:409–417
- Franks S: Polycystic ovary syndrome. N Engl J Med 1995; 333:853–861
- Polson DW, Adams J, Wadsword J, Franks S: Polycystic ovaries: A common finding in normal women. Lancet 1988; 1:870–872
- Kato I, Toniolo P, Koenig KL, Shore RE, Zeleniuch-Jacquotte A, Akhmedkhanov A, Riboli E: Epidemiologic correlates with menstrual cycle length in middle aged women. Eur J Epidemiol 1999; 15:809–814
- Lake JK, Power C, Cole TJ: Women's reproductive health: The role of body mass index in early and adult life. Int J Obes Relat Metab Disord 1997; 21:432–438